Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases.
Investigation of gene-gene interactions between CD40 and CD40L in Polish multiple sclerosis patients.
'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared.
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.
Patients with multiple sclerosis do not necessarily consume more alcohol or tobacco than the general population.
Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range.
Direct MRI detection of impending plaque development in multiple sclerosis.
Visualization of the medial forebrain bundle using diffusion tensor imaging.
Management of neurogenic bladder in patients with multiple sclerosis.
Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosis.
Alterations in nerve-evoked bladder contractions in a coronavirus-induced mouse model of multiple sclerosis.
Assessment of plasma brain-derived neurotrophic factor (BDNF), activity-dependent neurotrophin protein (ADNP) and vasoactive intestinal peptide (VIP) concentrations in treatment-naïve humans with multiple sclerosis.
The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis.
Rad51 Activates Polyomavirus JC Early Transcription.
Four FCRL3 Gene Polymorphisms (FCRL3_3, _5, _6, _8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study.
Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients.
Objectively Quantified Physical Activity in Persons with Multiple Sclerosis.
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis.
Role of Autoantibodies in Acquired Inflammatory Demyelinating Diseases of the Central Nervous System in Children.
The Effect of Neural Lesion Type on Botulinum Toxin Dosage: A Retrospective Chart Review.
The role of percutaneous balloon compression in the treatment of trigeminal neuralgia recurring after other surgical procedures.
Evaluation of axonal optic nerve damage using visual evoked potentials and optical coherence tomography in patients with multiple sclerosis.
Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.
Profilometry: A new statistical framework for the characterization of white matter pathways, with application to multiple sclerosis.
Depression during multiple sclerosis relapse: relation to disability and relapse severity.
Pages
« first
‹ previous
…
621
622
623
624
625
626
627
628
629
…
next ›
last »